MedDataX Logo

Double Blind Placebo Controlled Bellis Perenis and Arnica Montana as a Drug for PPH

NCT ID: NCT00405626

Last Updated: 2006-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To look at the antihemmorhagic effect of 2 homeopathic drugs in women post delivery Bellis Perenis and Arnica montana compare it with placebo

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhage

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

post partum hemmorhage,Arnica montana,Bellis Perenis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bellis Perenis ,Arnica montana

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy women during delivery

Exclusion Criteria

* Scarred uterus, multifetal ,multiparty,bleeding problems,cesarean sectons,chorioamnionitis
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shaare Zedek Medical Center

OTHER

Sponsor Role collaborator

Hadassah Medical Organization

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Mankuta

Role: STUDY_CHAIR

Hadassah University Medical Organization

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haddasah Medical Organization

Jerusalem, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David Mankuta, MD

Role: CONTACT

Phone: 5791070

Email: [email protected]

Menachem Oberbaum, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

David Mankuta, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Oberbaum M, Galoyan N, Lerner-Geva L, Singer SR, Grisaru S, Shashar D, Samueloff A. The effect of the homeopathic remedies Arnica montana and Bellis perennis on mild postpartum bleeding--a randomized, double-blind, placebo-controlled study--preliminary results. Complement Ther Med. 2005 Jun;13(2):87-90. doi: 10.1016/j.ctim.2005.03.006.

Reference Type RESULT
PMID: 16036165 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Hompostpartum-HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id